Table 3.
Entire Cohort | Northeast | South | Midwest | West | P for Interaction | |
---|---|---|---|---|---|---|
Percentage |
||||||
Aspirin on admission | 0.002 | |||||
Overall | 85.4 | 85.9 | 84.9 | 84.7 | 86.5 | |
White | 85.3 | 85.9 | 84.7 | 84.8 | 86.6 | |
Black | 85.6 | 84.5 | 86.6 | 83.7 | 85.4 | |
P value | 0.54 | 0.12 | <0.001 | 0.21 | 0.39 | |
Beta-blockers on admission | 0.47 | |||||
Overall | 42.1 | 39.7 | 42.6 | 43.2 | 43.5 | |
White | 42.3 | 39.8 | 42.9 | 43.4 | 43.7 | |
Black | 39.5 | 38.6 | 39.7 | 39.5 | 39.6 | |
P value | <0.001 | 0.38 | <0.001 | 0.001 | 0.03 | |
Aspirin at discharge | 0.08 | |||||
Overall | 34.7 | 36.3 | 32.8 | 32.1 | 40.6 | |
White | 34.4 | 36.2 | 32.2 | 31.8 | 40.5 | |
Black | 38.8 | 39.8 | 38.5 | 35.9 | 45.4 | |
P value | <0.001 | 0.005 | <0.001 | <0.001 | 0.01 | |
Beta-blockers at discharge | 0.75 | |||||
Overall | 18.8 | 17.0 | 18.6 | 19.0 | 22.2 | |
White | 18.8 | 17.0 | 18.4 | 19.0 | 22.2 | |
Black | 19.8 | 17.1 | 19.7 | 20.5 | 23.9 | |
P value | 0.02 | 0.96 | 0.02 | 0.11 | 0.28 |